Nevertheless, Bender and Ullrich (2012) have found that RSK4 overexpression is associated with sunitinib resistance in RCC cell lines, indicating that RSK4 may regulate treatment resistance and could promote tumour progression.
In Apc-mutant mouse mammary glands during lactation, expression of the ATP-binding cassette sub-family G member 2/Breast cancer resistance protein (ABCG2/BCRP) was altered [ 11], suggesting that APC may regulate therapeutic resistance through mediation of ATP-binding cassette transporters.
The molecular mechanisms by which CaMs may regulate disease resistance are unknown.
Taken together, these findings suggested that RFP may regulate carboplatin resistance through modulating p53 activity or expression.
Finally, we show that NPHP1 trafficking to cilia does not require PC-1 and that PC-1 may require NPHP1 to regulate resistance to apoptosis, but not to regulate cell cycle progression.
Studies with nematodes [ 35- 38], Drosophila [ 39- 42], and rodents [ 43- 49] suggest that the molecular processes that regulate aging and longevity may be similar to those that regulate resistance to oxidative stress.
Studies with nematodes [ 26- 29], Drosophila [ 30- 33], and rodents [ 34- 40] suggest that the molecular processes that regulate aging and longevity may be similar to those that regulate resistance to oxidative stress.
Thus, we propose that insulin resistance may regulate DNMT1 activity and DNA methylation in the D-loop region through NAD+-SIRT1, and this mechanism should be further explored in future studies.
In fact, experimental data indicates that Src and PTEN may regulate each other to promote trastuzumab resistance.
The present study demonstrates that ECM1 may regulate both cancer cell proliferation and Ttzm resistance through interaction with EGF signaling.
